肺癌是癌症死亡的首要原因，对香港及全球人口均构成重大的公共卫生挑战。肺癌患者经常经历一组令人困扰的症状群，其特征为呼吸困难驱动的呼吸困扰，并伴随持续咳嗽及疲劳，整体造成沉重的疾病负担。
适应症：Symptom Cluster、Breathlessness、Coughing、Fatigue Symptom、Lung Cancer Patients、Brain Activity
入组条件
纳入标准
- HK patients who can understand Cantonese, aged 18 years or older;
- A confirmed diagnosis of an intrathoracic malignancy, including small cell lung cancer, non-small cell lung cancer, or mesothelioma; at any stage of cancer treatment or palliative care;
- Self-reported impact on daily life from at least two of the three symptoms, where one symptom is breathlessness;
- Stability of COPD, if present;
- WHO Performance Status of 0-2;
- fMRI can be conducted;
- Expected lifespan of more than six months.
排除标准
- Cognitive impairments, severe psychotic symptoms, or other medical conditions that might hinder participation;
- Participating in mindfulness or other psychological support interventions or symptom management interventions.
入组条件维持 ClinicalTrials.gov 原始英文登记资料，实际入组资格以研究团队的正式评估与受试者知情同意书为准。资料来源：ClinicalTrials.gov，每两周自动更新，最后同步：2026年10月8日。